Early effects of ozoralizumab 30 mg in patients with rheumatoid arthritis and inadequate response to methotrexate: a post hoc trajectory analysis of the phase II/III OHZORA trial

Early effects of ozoralizumab 30 mg in patients with rheumatoid arthritis and inadequate response to methotrexate: a post hoc trajectory analysis of the phase II/III OHZORA trial

Objective This study assessed the early effects of ozoralizumab (OZR) 30 mg in patients with rheumatoid arthritis (RA) with inadequate response to methotrexate (MTX-IR), drawing on OHZORA trial data for efficacy and safety insights.Methods The study included 141 patients with RA from the OHZORA tria...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tsutomu Takeuchi, Yoshiya Tanaka, Yusuke Miyazaki, Nobuko Horiuchi, Shunsuke Okamoto, Rumiko Matsumoto
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-06-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/11/2/e005710.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of Ozoralizumab Administration with or without Methotrexate in Patients with Rheumatoid Arthritis: A Post-Hoc Analysis
by: Yoshiya Tanaka, et al.
Published: (2025-01-01)

Efficacy of Ozoralizumab vs. Golimumab for Rheumatoid Arthritis: A Systematic Review
by: Nathania Elma Fithriyah, et al.
Published: (2025-07-01)

Upadacitinib as monotherapy in patients with rheumatoid arthritis and prior inadequate response to methotrexate: results at 260 weeks from the SELECT-MONOTHERAPY randomised study
by: Josef S Smolen, et al.
Published: (2025-05-01)

Efficacy and safety of sarilumab in combination with methotrexate in patients with active rheumatoid arthritis and inadequate effect of methotrexate monotherapy (results of phase III MOBILITY study)
by: E. L. Nasonov, et al.
Published: (2019-05-01)

Filgotinib Radiographic and Clinical Efficacy Versus Other JAK Inhibitors and Adalimumab in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate: A Systematic Review and Network Meta-Analysis
by: Yoshiya Tanaka, et al.
Published: (2025-04-01)

Correction: Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis
Published: (2024-11-01)

A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate
by: Walid Fakhouri, et al.
Published: (2020-04-01)

Protocol: Filgotinib in addition to methotrexate versus filgotinib monotherapy in patients with rheumatoid arthritis with an inadequate response to methotrexate: A multicenter, prospective, open-label, randomized controlled trial (FAITHFUL Study).
by: Mitsuhiro Akiyama, et al.
Published: (2025-01-01)

Effects of immunotherapy on isolated optic neuritis associated with ozoralizumab, a novel anti-tumor necrosis factor α NANOBODY® compound: A case report
by: Masato Okitsu, et al.
Published: (2025-06-01)

An In Vitro Study of the Effects of Methotrexate Loaded Biocomposite Beads on MG63 Osteoblast Cells
by: A. E. Malash, et al.
Published: (2025-01-01)

Inadequate Lymph Node Yield: An Inadequate Indication for Adjuvant Chemotherapy in Stage II Colon Cancer
by: Alan Zambeli-Ljepović, MD, MHS, et al.
Published: (2023-12-01)

Clinical Holistic Medicine: When Biomedicine is Inadequate
by: Søren Ventegodt, et al.
Published: (2004-01-01)

Ghanaians Might Be at Risk of Inadequate Dietary Intake of Potassium
by: David Oscar Yawson, et al.
Published: (2016-01-01)

Homeless and inadequately housed people in the Brussels-Capital Region
by: Benoît Quittelier, et al.
Published: (2019-11-01)

High-dose methotrexate
by: Manikandan Dhanushkodi
Published: (2019-01-01)

Methotrexate Associated Renal Impairment Is Related to Delayed Elimination of High-Dose Methotrexate
by: Shi-Long Yang, et al.
Published: (2015-01-01)

Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study
by: E. Feist, et al.
Published: (2023-04-01)

Blackleg in inadequately immunized calves and their recovery following antibiotic therapy
by: Carolina C Guizelini, et al.
Published: (2020-07-01)

Reporting of Race, Ethnicity, and Ancestry Remains Inadequate in Kidney Research
by: Jian Roushani, et al.
Published: (2024-11-01)

Retracted: Ghanaians Might Be at Risk of Inadequate Dietary Intake of Potassium
by: Journal of Nutrition and Metabolism
Published: (2017-01-01)

Inadequate representation of individuals of African ancestry in pharmacogenetics of tamoxifen research
by: Keneuoe Cecilia Nthontho, et al.
Published: (2024-09-01)

Care of Patients With Inflammatory Bowel Disease With Inadequate Response or Intolerance to Upadacitinib
by: Lynn Kobeissi, et al.
Published: (2025-01-01)

Inadequate clearance of translocated bacterial products in HIV-infected humanized mice.
by: Ursula Hofer, et al.
Published: (2010-04-01)

Amplification of drug resistance against the background of inadequate chemotherapy for pulmonary tuberculosis
by: I. A. Burmistrova, et al.
Published: (2019-09-01)

Diagnosis and molecular typing of rabies virus in samples stored in inadequate conditions
by: Fernando J Beltran, et al.
Published: (2014-08-01)

Was the balanced stratified coverage sampling not well spatially distributed, or was it inadequately implemented?
by: Abdelkrim Bouasria
Published: (2025-08-01)

The American Thoracic Society’s Spirometric Criteria Alone is Inadequate in Asthma Diagnosis
by: John A Gjevre, et al.
Published: (2006-01-01)

Sadness in young children and the inadequate development of inner outer containment in childhood
by: Christiaan Bezuidenhout, et al.
Published: (2024-12-01)

Inadequate Models of Stereochemistry Based on Kimball’s Spheres and Pauli’s Exclusion Principle
by: Christian K. Jørgensen
Published: (1977-11-01)

Drug resistant epilepsy as the consequence of inadequate control of type 1 diabetes
by: Ewa M. Sokolewicz, et al.
Published: (2024-04-01)

Novel Sutureless Scleral Fixated IOL for Inadequate or Absent Capsular Support
by: Georgios Sidiropoulos, et al.
Published: (2022-01-01)

Methotrexate in the treatment of rheumatic disease
by: Marina Zinovyevna Kanevskaya, et al.
Published: (2013-12-01)

Methotrexate-Induced Pulmonary Toxicity
by: Baruch D Jakubovic, et al.
Published: (2013-01-01)

Methotrexate toxicity presenting as pancytopenia
by: M. C. R. Rama, et al.
Published: (2024-11-01)

Enhancing ovarian cancer treatment: Synergistic effects of methotrexate (Methotrexate)- and quercetin-loaded chitosan nanoparticles
by: Hamed Dadashi, et al.
Published: (2024-12-01)

SCREEN: QUID EST HOC? / ЭКРАН: QUID EST HOC?
by: DUKOV E.V. / ДУКОВ Е.В.
Published: (2017-03-01)

Methotrexate-Associated Lymphoproliferative Disorder with Intraocular Involvement Improved with Intravitreal Methotrexate and Chemotherapy: A Case Report
by: Atsushi Yamasaki, et al.
Published: (2024-11-01)

Insulin Predicts Methotrexate Response by Affecting the Transcription of Methotrexate Target Genes in the Treatment-Naive Rheumatoid Arthritis
by: Victoria M. E. Lundgren, et al.
Published: (2025-06-01)

EFFICACY AND SAFETY OF COMBINATION TREATMENT WITH ABATACEPT AND METHOTREXATE AND MONOTHERAPY WITH METHOTREXATE IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: V. A. Kel'tsev, et al.
Published: (2012-11-01)

Simultaneous Quantification of Methotrexate and Its Metabolite 7-Hydroxy-Methotrexate in Human Plasma for Therapeutic Drug Monitoring
by: Xinxin Ren, et al.
Published: (2019-01-01)